Abstract
Flavonoids are chromene analogues abundantly found in plants. It has always been of interest to discover natural flavonoid structures, since living things, including humans, are routinely exposed to these compounds through many dietaries. So far, numerous studies have been conducted on flavonoids with diverse biological actions. The activity results obtained, particularly regarding the effects of flavonoids on various validated and non-validated targets of Alzheimer’s Disease (AD), make these compounds promising agents either to be directly employed in clinical trials or to be utilized as important scaffolds for flavonoid-based drug design studies. Although there are many review articles on the treatment and protective effects of flavonoids on AD, within this review, the effects of flavonoids on mitochondrial dysfunction developing throughout AD have been presented concomitant to their structural organization.
Keywords: Flavonoids, Alzheimer's disease, mitochondrial dysfunction, reactive oxygen species, amyloid beta, chromene analogues.
Graphical Abstract
Current Drug Targets
Title:Amendatory Effect of Flavonoids in Alzheimer's Disease Against Mitochondrial Dysfunction
Volume: 22 Issue: 14
Author(s): Hayrettin O. Gulcan and Ilkay E. Orhan*
Affiliation:
- Department of Pharmacognosy, Faculty of Pharmacy, Gazi University, 06330 Ankara,Turkey
Keywords: Flavonoids, Alzheimer's disease, mitochondrial dysfunction, reactive oxygen species, amyloid beta, chromene analogues.
Abstract: Flavonoids are chromene analogues abundantly found in plants. It has always been of interest to discover natural flavonoid structures, since living things, including humans, are routinely exposed to these compounds through many dietaries. So far, numerous studies have been conducted on flavonoids with diverse biological actions. The activity results obtained, particularly regarding the effects of flavonoids on various validated and non-validated targets of Alzheimer’s Disease (AD), make these compounds promising agents either to be directly employed in clinical trials or to be utilized as important scaffolds for flavonoid-based drug design studies. Although there are many review articles on the treatment and protective effects of flavonoids on AD, within this review, the effects of flavonoids on mitochondrial dysfunction developing throughout AD have been presented concomitant to their structural organization.
Export Options
About this article
Cite this article as:
Gulcan O. Hayrettin and Orhan E. Ilkay *, Amendatory Effect of Flavonoids in Alzheimer's Disease Against Mitochondrial Dysfunction, Current Drug Targets 2021; 22 (14) . https://dx.doi.org/10.2174/1389450122666210120144921
DOI https://dx.doi.org/10.2174/1389450122666210120144921 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Multi-Target Inhibitors for Proteins Associated with Alzheimer: In Silico Discovery using Fragment-Based Descriptors
Current Alzheimer Research Targeting Tumor Proteasome with Traditional Chinese Medicine
Current Drug Discovery Technologies An Update on “Selenium Containing Compounds from Poison to Drug Candidates: A Review on the GPx-like Activity”
Current Chemical Biology Synthesis and Anticancer Activity of Phthalimido and Naphthalimido Substituted Dihydropyrimidone Conjugates
Letters in Drug Design & Discovery Inhaled Biologics: From Preclinical to Product Approval
Current Pharmaceutical Design Identifying Ligand-receptor Interactions <i>via</i> an Integrated Fuzzy Model
Current Proteomics Physicochemical Characterization of Nano- and Microparticles
Current Nanoscience PD-L1 Testing for Urothelial Carcinoma: Interchangeability, Reliability and Future Perspectives
Current Drug Targets L-Proline Catalyzed Synthesis of Novel 5-{[2-(2-phenylpiperazin-1-yl)quinolin] methylene}-2,4-dione Derivatives
Letters in Organic Chemistry Advances and Challenges in Kidney Organoids
Current Stem Cell Research & Therapy Metabolite Interference in Pharmacokinetic Studies
Drug Metabolism Letters α,β-Acetylenic Amino Thiolester Inhibitors of Aldehyde Dehydrogenases 1&3: Suppressors of Apoptogenic Aldehyde Oxidation and Activators of Apoptosis
Current Medicinal Chemistry The Antitumor Efficiency of Zinc Finger Nuclease Combined with Cisplatin and Trichostatin A in Cervical Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry A Synopsis on the Role of Human Papilloma Virus Infection in Cervical Cancer
Current Drug Metabolism Gene Expression Profile Classification: A Review
Current Bioinformatics Nanomagnets-From Fundamental Physics to Biomedicine
Current Nanoscience Recognition of Anions by bis Urea based Fluorescent Receptors
Letters in Organic Chemistry Review on Digital Breast Tomosynthesis Patents
Recent Patents on Biomedical Engineering (Discontinued) Seeing Genes at Work in the Living Brain with Non-Invasive Molecular Imaging
Current Gene Therapy Implications of Fibroblast Growth Factors (FGFs) in Cancer: From Prognostic to Therapeutic Applications
Current Drug Targets